Genetic engineering enables the construction of gene man Genome Project (5), efficient and robust production and purification strategies are necessary (6). For fusions resulting in fusion proteins having the combined properties of the original gene products. Fusion industrial production of recombinant proteins, simple and fast purification methods introduced as an early can be made on either or both sides of the target gene depending on the specific application, but the majority unit operation can improve the overall economy of the process. A powerful purification technique made possiof the described fusion protein systems place the protein of interest at the C-terminal end of a well-charac-ble by the introduction of genetic engineering is to purify the target protein by the use of a genetically fused terized fusion partner. Many different applications for fusion proteins in widespread areas of biotechnology affinity fusion partner. Such fusion proteins can often be purified to near homogeneity from crude biological have been reported (1-3), including a facilitated purification of the target protein, means to decrease prote-mixtures by a single, and fusion-partner-specific, affinity chromatography step. olysis of the target protein, display of proteins on surfaces of cells and phage, and construction of reporter To date, a large number of different gene fusion systems, involving fusion partners that range in size from molecules for the monitoring of gene expression and protein localization as well as to increase the circula-one amino acid to whole proteins capable of selective interaction with a ligand immobilized onto a chromation half-life of protein therapeutics. However, as pioneered by Uhlén and co-workers in 1983 (4), the most tography matrix, have been described. In such systems, different types of interactions, such as enzyme-subfrequent application of gene fusions has been for the purpose of affinity purification of recombinant proteins. strate, bacterial receptor-serum protein, polyhistidines-metal ion, and antibody-antigen, have been utiThis review focuses on the use of affinity tag fusions for detection, purification, and immobilization of re-lized (7). The conditions for purification differ from system to system and the environment tolerated by the combinant proteins. A general overview of commonly used affinity tags is followed by some recent examples target protein is an important factor for deciding which affinity fusion partner to choose. In addition, other facof specific applications for affinity tags and a discussion concerning possible future trends.
tors, including protein localization, costs for the affinity matrix and buffers, and the possibilities of removing the fusion partner by site-specific cleavage, should also
AFFINITY FUSION PARTNERS
be considered. Numerous gene fusion systems for afThere is a great interest in developing methods for finity purification have been described in the literature, fast and convenient purification of proteins. For exam-all with different characteristics (3,7-10). Some of the ple, to facilitate functional and structural studies of most commonly used systems are listed in Table 1 , toproteins derived from the rapidly growing number of gether with their respective elution condition(s) and genes coming out of genome programs such as the Hu-agents suitable for specific detection of expressed fusion proteins. The introduction of a recognition sequence for a the affinity tag may be left on the target protein, e.g.: ing novel affinity matrices utilizing an immobilized target protein (20) . (i) to function as immunogens for the generation and purification of antibodies (6,11-13); (ii) when the analysis of the biological activity of the target protein is Staphylococcal Protein A and Its Derivative Z unaffected by the affinity fusion partner (14-23); (iii) Staphylococcal protein A (SPA) is an immunoglobufor directed immobilization of the target protein lin-binding receptor present on the surface of the gram-(6, 12, 20, [23] [24] [25] [26] [27] .
positive bacterium Staphylococcus aureus. The strong In order to study different interactions between bio-and specific interaction between SPA and the constant molecules, e.g., protein-protein, protein-DNA (RNA), part (Fc) of certain immunoglobulins (Ig) has made it it is indeed convenient to have the interacting protein useful for the purification and detection of immunoimmobilized in a directed manner via an affinity tag. globulins in a variety of different applications (31, 32) . This strategy has been employed when biomolecular SPA is capable of binding to the constant part of IgG interactions have been characterized in dedicated in-from a large number of different species including man struments, i.e., biosensors (27) . Furthermore, immobi-(31,33). In addition, SPA has the capacity to bind to a lization of enzymes can be used to obtain bioreactors limited number of Fab fragments containing certain or to facilitate removal or reuse of the biocatalyst and VH sequences (34, 35) . The cloning and sequencing of to alter the characteristics of the immobilized enzyme the SPA gene revealed a highly repetitive organization or the intended reaction (23, 28, 29) . Cysteine residues of the protein that could be divided into a signal sehave been used to achieve directed immobilization quence followed by five homologous domains (E, D, A, (24, 30) , but this strategy has the drawback that added B, and C) and a cell surface anchoring sequence decysteines can be involved in the formation of unwanted noted XM ( Fig. 1) (36,37) . It was later shown that all intra-or intermolecular disulfides. Also polyhistidine five domains of SPA were separately capable of binding and polyarginine tags have been utilized to achieve a directed immobilization (25, 26) , but additional interactions between the affinity matrices used (IMAC or ionexchange resins) and the target protein might disturb the intended orientation of the immobilization. An interesting alternative is to use an in vivo biotinylated affinity fusion partner for immobilization of the fusion protein onto streptavidin-or avidin-coated surfaces (20, 27 one of its affinity activities is also a strategy for creat-IgG (38). The isolation of the gene made it possible to take advantage of different extensions of the receptor for use as affinity fusion partners, allowing one-step IgG-affinity purification of target proteins (Table 1) (40) . (ii) The N-and C-termini of the three-helix bundle and the extensions of various serum albumin-binding subfragments structure of an individual IgG-binding SPA domain are described in the text. S, signal peptide (processed during secretion); solvent exposed (41-44), which favors an independent W, cell wall anchoring region. The regions responsible for serum folding of a fused target protein and the SPA fusion albumin and immunoglobulin binding, respectively, are marked by arrows.
partner; (iii) SPA does not contain any cysteine residues that could interfere with the disulfide formation within a fused target protein (36). (iv) SPA is highly soluble and renatures efficiently after having been sub-cocci and is capable of binding to both IgG and serum albumin (63-65). The structure is highly repetitive jected to denaturants such as urea and guanidiniumHCl, which facilitates the refolding of SPA fusion pro-with several structurally and functionally different domains (66,67). The regions responsible for the affinities teins from inclusion bodies or the ''reshuffling'' of misfolded or multimeric forms of disulfide-bridged target to serum albumin and IgG, respectively, are structurally separated, which allowed for the subcloning of proteins (45) (46) (47) (48) (49) . In addition, SPA fusion proteins can be produced to high levels within the E. coli cell and fragments displaying serum albumin binding only (Fig. 2) (65). The serum albumin binding region has been still remain soluble (6,18). (v) It has been demonstrated that it is possible to introduce different protease recog-proposed to contain three binding motifs (ca. 5 kDa each), of which one has been structurally determined nition sequences accessible for site-specific cleavage of SPA fusion proteins to release the target protein showing a three-helix bundle domain, surprisingly similar in structure to an IgG-binding domain of SPA (48, 50) . (vi) The SPA fusion partner is secretion competent, and SPA fusions can be efficiently secreted to the (68, 69) . The region binds to serum albumins from different species with various affinities and shows strong E. coli periplasm and in some cases also to the culture medium, using the SPA promoter and signal sequence binding to human serum albumin (HSA) (70) . Expression in E. coli has demonstrated that the region shows (51) (52) (53) (54) (55) .
To allow chemical cleavage of SPA fusion proteins a high proteolytic stability, is highly soluble, and can be efficiently secreted (6,12,65,71). with both CNBr and hydroxylamine, an engineered domain based on domain B lacking methionine was deDifferent parts of the region, denoted BB, ABP (albumin binding protein) or ABD (albumin-binding domain) signed. In this new domain, designated Z (Table 1) , the glycine residue in a hydroxylamine sensitive Asn-Gly (Fig. 2) have been utilized as fusion partners, allowing one-step HSA-affinity chromatography purification of sequence was replaced by alanine, making it resistant to either of these chemical agents ( Fig. 1) (76, 77) , have domain have replaced the original SPA fusion partner. Analysis of different repeats of Z binding to IgG showed successfully been used to produce BB or ABP fusion proteins. that there was no advantage in using more than two Z domains (24) . A number of different expression vec-ABP and protein A (Z) fusion proteins are most conveniently eluted from affinity columns using low pH tors for E. coli production of Z or ZZ fusions in which the fusion protein either is exported (12, (57) (58) (59) or kept (e.g., acetic acid of pH É 3). However, low pH can in some instances be destructive for target protein funcintracellularly (6,18,48,49,60,61) have been developed. SPA and ZZ fusion proteins have also been successfully tion and must in such cases be avoided. In addition, the use of low pH eluents following an initial capture expressed in alternative hosts such as gram-positive bacteria, yeast, plant cells, Chinese hamster ovary of a fusion protein at physiological pH, could result in passage of the pH through the isoelectric point (pI) of (CHO) cells, and insect cells (40, 62 (72) , and heat binding region BB, allowing a means to specifically remove the competitor after elution via a second affinity function. Thus, the excess of competitor present in the eluate is captured through a simple HSA-affinity chromatography step. In addition, the strategy allows also for the reuse of the ZZ-BB competitor after elution of the fusion protein from the column. Furthermore, the ZZ-BB competitor should also be useful for effective competitive elution of monovalent albumin-binding domain fusion proteins.
The inherent properties of the serum albumin-binding fusion partners could make such fusion proteins of particular interest for delivery of protein therapeutics, as well as for administration of subunit vaccines. The strong and specific binding to serum albumin has been proposed to be responsible for the increased in vivo stability seen for otherwise rapidly cleared proteins (75, 78) . Serum albumin, which is the most abundant protein in serum, has a long half-life itself (19 days in humans) (79) and could therefore act as a ''stabilizer'' of sensitive proteins via a serum albumin-binding fusion partner. It has been demonstrated that the half-life in mice of a CD4 fragment (the target receptor for human immunodeficiency virus) could be significantly increased by fusion to BB (78) . Likewise, fusion to different serum albumin-binding fragments of SpG was shown to increase the serum half-life of human soluble complement receptor type 1 (sCR1) in rats (75) .
The serum albumin-binding region of SpG seems to have immunopotentiating properties, when used as a carrier protein genetically fused to a protein immunogen used for immunization (73). Recently, it was demonstrated that a BB fusion protein, BB-M3 containing a malaria peptide, M3, induced significant antibody responses in mice strains that were nonresponders to the malaria peptide alone or when fused to a different affinity fusion partner, suggesting that BB fusion partner has the ability to provide T-cell help for antibody production (80) .
Polyhistidine Tags
In 1975 a new concept for affinity purification of proteins was presented by Porath and co-workers (81, 82) . The method is based on the interaction between the side chains of certain amino acids, particularly histi- dines, on a protein surface and immobilized transition metal ions, and is today known as immobilized metal ion affinity chromatography (IMAC). The metal ions are immobilized by the use of a chelating agent capable (ú70ЊC) (23) . A general concept for mild elution of Z or ABD fusion proteins, based on competition, was re-of presenting the metals for binding to the protein. Several gene fusion systems employing histidine-rich tags cently devised (Fig. 3) (18) . The target protein fused to a single Z domain is efficiently eluted by competition for purification of recombinant proteins on immobilized metal ions have since then been described (Table 1 ) (9). with a divalent ZZ competitor protein having a more than 10-fold higher apparent affinity for hIgG. The ZZ Tags, either N-or C-terminal, consisting of consecutive histidine residues binding selectively to immobilized domains were fused to the divalent serum albumin Ni 2/ ions were described by Hochuli and co-workers straints for metal ion binding. Such ''histidine patch'' thioredoxins could find broad use as fusion partners (83) . Adsorption of the poly-His-tagged proteins to a metal-chelate adsorbent was performed at neutral or since they combine two beneficial features, high solubility and the possibility of using affinity chromatogslightly alkaline pH, at which the imidazole group of the histidines is not protonated (84) . The expressed raphy for purification. fusion proteins were recovered with a purity of more than 90% in a single step using a Ni 2/ -nitrilotriacetic In Vivo Biotinylated Affinity Tags acid (NTA) adsorbent and elution with low pH or by competition using imidazole (83, 84) .
The strong binding (K d Ç 10 015 M) between biotin and avidin or streptavidin (108 -110) is frequently Other research groups have described the use of alternative chelators such as iminodiacetic acid (IDA) used in biochemistry and molecular biology for immobilization and detection purposes. For use in such ap- (27, (85) (86) (87) (88) or Talon (Clontech) as well as other Hiscontaining tag sequences such as variants also con-plications, biotinylation of proteins is most frequently achieved through a covalent coupling of biotin to the taining Trp residues (85, 89) or multiple copies of the peptide Ala-His-Gly-His-Arg-Pro (86) . For IMAC protein by the use of biotin-ester reagents that preferentially modify lysine residues (111). However, such purification of various His-Trp containing fusion proteins, the use of Co 2/ or Zn 2/ rather than Ni 2/ as the coupling is difficult to direct to a specific position and can occur at several residues, some of which might be immobilized metal ion has been shown to lead to less contamination of E. coli proteins (89) . General expres-important for the protein structure and/or activity.
An elegant strategy for site-specific biotinylation of sion vectors for both intracellular (27, 87, (90) (91) (92) (93) and secreted production (94,95) of hexahistidine (His 6 ) fu-recombinant proteins during their production was demonstrated by Cronan, utilizing the in vivo biotinysion proteins in E. coli have been developed. Furthermore, His 6 sequences have also been employed in the lation machinery of E. coli (112) . Analysis of various extensions of the naturally biotinylated 1.3 S subunit production and purification of dual affinity fusions in E. coli in combination with a modified S-peptide of ribo-of Propionibacterium shermanii transcarboxylase (113) showed that a 75-residue fragment was suffinuclease A (96,97), the albumin-binding protein ABP (22) , or the GST fusion partner (98). The use of polyhis-cient to serve as substrate for biotinylation. Thus, fusion proteins containing in vivo biotinylated domains tidines as fusion partners for purification has been demonstrated for recombinant fusion proteins pro-could be purified by affinity chromatography employing immobilized monovalent avidin (114) , and duced in a wide range of host cells other than E. coli: Saccharomyces cerevisiae (13, 99) , mammalian cells subsequently eluted with free biotin for mild elution (112) . The stability of the avidin ligand also allows (88,100), and baculovirus-infected Spodoptera frugiperda insect cells (101, 102) .
the capture of proteins under denaturing conditions, such as in the presence of 1% sodium dodecyl sulfate An important advantage of the His 6 affinity tag is the possibility of purifying proteins under denaturing (SDS) or 8 M urea (112) . Reusable matrices can also be obtained by chemical modification (nitration) of tyconditions. Thus, proteins that have aggregated into inclusion bodies can be dissolved in a suitable agent rosine in the biotin-binding sites of avidin and streptavidin. Such matrices called nitrostreptavidin or nisuch as urea or Gu-HCl and purified by IMAC. Refolding of the target protein can then be performed without troavidin allow for elution of biotin-containing proteins by free biotin or alkaline pH (pH 10) (115). interference from other proteins (84, 103) . Furthermore, small affinity tags such as the His 6 peptide can Few proteins are naturally modified by biotin incorporation. In E. coli only one such protein, the biotin easily be genetically fused to a target gene by polymerase chain reaction (PCR) techniques (62,104). Also, the carboxyl carrier protein (BCCP) of acetyl-CoA carboxylase, has been found (116) . The biotin is covalently strong interaction between polyhistidine tags and immobilized Ni 2/ ions has been demonstrated to result in attached to a specific lysine residue, a reaction catalyzed by biotin ligase (BirA) (112, 113, 117) . The C-tera directed immobilization of the fused target protein, allowing protein-protein or protein-DNA interaction minal 101 residues of the E. coli BCCP protein have been utilized successfully as an affinity handle for prostudies (25, 90, 105) . However, when attached to recombinantly expressed DNA-binding proteins, histidine duction and purification of a Fab antibody fragment in E. coli (20) . The fusion protein was secreted into the tails have been reported to influence the DNA-binding properties (106).
culture medium and then purified on streptavidin agarose beads, resulting in a simultaneous directed immoAn interesting extension of the IMAC technology has been described by Lu and co-workers (107) . Using bilization of the antibody fragment allowing one-step immunoaffinity purification of a recombinant human the solubilizing E. coli thioredoxin protein as presentation scaffold, histidine residues were introduced at tumor necrosis factor a (TNF) fusion protein. If desired, biotinylated proteins bound to streptavidin can be different positions that satisfied the geometrical con-eluted by boiling in an SDS-urea solution (118) (20, 122) . bidopsis thaliana have been used to produce biotinmodified fusion proteins in E. coli (112, 119) . The 1.3 S subunit of P. shermanii transcarboxylase has also been Glutathione S-Transferase described to function as a biotinylated fusion partner
The glutathione S-transferases (GST) are a family of in recombinant Semliki Forest virus-infected baby enzymes that can transfer sulfur from glutathione to hamster kidney (BHK) and CHO cells (120).
substances such as nitro and halogenated compounds, From a combinatorial library of short peptides, se-leading to their detoxication (127) . Many mammalian quences capable of mimicking the normal BirA sub-GSTs can be purified by affinity chromatography using strate were found using an elegant selection strategy the immobilized cofactor glutathione, followed by combased on fusion of the peptides to a plasmid binding petitive elution with reduced glutathione (128) . Based lac repressor protein (121) . A family of sequences (ca. on this specific interaction, a gene fusion system for E. 13 aa) were found to be in vivo biotinylated at a central coli expression was developed by Smith and co-workers invariant lysine residue and could replace the larger in (129), using GST from the parasitic helminth Schistovivo biotinylated fusion partners used earlier by other soma japonicum (Table 1) . They demonstrated that a groups. Recently, such short tags have found use in number of eukaryotic proteins fused to the C-terminus different purification and immobilization situations of GST could efficiently be purified from a crude E. (27, 122) .
coli lysate by glutathione-affinity chromatography. In An alternative small affinity tag (nonbiotinylated) addition, cleavage sites for the proteases thrombin and that binds to streptavidin has been found in a peptide blood coagulation factor Xa had been introduced to library screened for peptides that mimic biotin (123) . allow removal of the GST fusion partner (129) . It has A nine-amino-acid streptavidin-binding peptide termed been demonstrated that GST fusion proteins can be strep-tag was selected from the library and used as a renaturated from inclusion bodies after solubilization C-terminal affinity fusion partner for purification of an using 6 M Gu-HCl and subsequently purified by gluta-E. coli expressed antibody Fv fragment by streptavidin-thione-affinity chromatography (130). Recently, a seaffinity chromatography. The fusion protein was com-ries of vectors was described allowing either N-or Cpetitively eluted with the biotin analog iminobiotin, terminal fusion of a target protein to GST for producwhich allowed for column regeneration by washing tion in E. coli (131) . Furthermore, two vectors have with the equilibration buffer. Such mild elution condi-been developed that allow, in addition to N-or C-termitions (diaminobiotin) have also been used in the strep-nal fusion to GST, site-specific in vitro 32 P labeling of tavidin-affinity chromatography purification of various the fusion protein after glutathione-affinity purificamembrane proteins captured via strep-tag fused Fv tion, employing a protein kinase recognizing an introfragments (124) . Recently, an improved version of the duced substrate sequence (132) . The GST fusion partpeptide, strep-tag II, was described (125) . In contrast ner has also been used as an N-terminal constituent to the original peptide, strep-tag II has the potential in a dual affinity fusion approach, in combination with to retain its streptavidin-binding activity when placed a His 6 tag at the C-terminus of a tripartite fusion proat positions other than the C-terminus. tein (98). Furthermore, expression vectors have been A possible complication associated with avidin/strep-constructed for production of GST fusion proteins in tavidin-affinity chromatography of in vivo biotinylated insect cells, S. cerevisiae, and COS-7 cells. (133) (134) (135) (136) . proteins is that any free biotin should preferentially be A possible complication associated with the GST fusion removed before loading the cell lysate onto the column, system is the use of reduced glutathione (a reducing to avoid blocking of the ligand. In addition, if not re-agent) for elution, which can affect target proteins conmoved in a first purification step, biotinylated host pro-taining disulfides (137). teins may be copurified with the biotinylated target protein. Recently, this problem was circumvented us-FLAG Peptide ing a combined affinity tag that enabled removal of biotin and BCCP by employing a first HSA-affinity An affinity gene fusion system that has become popular in recent years is the so-called FLAG system, chromatography step prior to immobilization of the affinity fusion protein onto a streptavidin surface (27) . A based on the fusion of an eight-amino-acid peptide to the target protein for immunoaffinity chromatography similar approach was described for the production of a BCCP-firefly luciferase fusion protein in which a His 6 on immobilized monoclonal antibodies. The FLAG peptide sequence (Asp-Tyr-Lys-Asp-Asp-Asp-Asptag was also included for IMAC purification, prior to immobilization of the fusion protein onto avidin-coated Lys) is hydrophilic and contains an internal enterokinase cleavage recognition sequence (Asp -Asp -Aspsurfaces (126) . To increase the fraction of biotinylated Asp -Lys) (138) . Monoclonal antibodies to the FLAG bodies followed by amylose-affinity purification has been demonstrated (148) . sequence were obtained after immunization of mice with a FLAG fusion protein. One monoclonal antibody (M1) was found to bind to FLAG fusion proteins in a SITE-SPECIFIC CLEAVAGE OF FUSION PROTEINS calcium-dependent manner, which allowed gentle eluFor certain applications it is necessary to remove the tion by the addition of a chelating agent (138, 139) . A affinity fusion partner after purification. For example, limitation of the M1 antibody is that it can only bind a fusion partner can cause unwanted immune rethe FLAG peptide when located at the extreme N-tersponses, alter the properties, or complicate a structural minus of the fusion protein. This limits the use of the determination of a fused target protein. Several meth-M1 antibody to the purification of fusions exposing an ods have been described for site-specific cleavage of fu-N-terminal FLAG peptide, such as after removal of a sion proteins based on chemical or enzymatic treatsignal peptide from a secreted FLAG fusion. Recently, ment of the fusion protein (9,149) and some relevant it was found that the M1 antibody binds with almost examples are listed in Table 2 . the same affinity to a shortened version of the FLAG Chemical cleavage methods are relatively inexpenpeptide, consisting only of the first four amino acids sive, but the rather harsh reaction conditions may lead (Asp-Tyr-Lys-Asp) (140) . Alternatively, a different to protein denaturation or amino acid side chain modimonoclonal antibody (M2), capable of binding to the fications of the target protein. Furthermore, the chemi-FLAG peptide also if it is preceded by a methionine at cals are relatively unspecific, which can lead to unthe N-terminus or fused to the C-terminus of the target wanted cleavages inside the target protein (149) . Enzyprotein, is available (141). However, the M2 antibody matic methods are preferred to chemical methods interacts with the FLAG peptide in a non-calcium-debecause they are generally more specific and the cleavpendent manner and a fusion protein can therefore not age can usually be performed under mild conditions be eluted with a chelating agent. Instead, low pH or (Table 2 ) (50,149). competition with an excess of synthetically produced After cleavage, the released affinity tag can be cap-FLAG peptide is used (Table 1 ) (141). Different hosts tured by passage of the cleavage mixture over an affinhave been used for production of FLAG fusion proteins, ity matrix while the target protein is obtained in the including E. coli, S. cerevisiae (138) , recombinant bacuflowthrough. However, in such schemes the protease is lovirus-infected S. frugiperda insect cells (101) , and still left with the target protein and must be removed COS-7 cells (142) .
to obtain a pure target protein. To circumvent this, affinity-tagging of the protease has been employed in Maltose-Binding Protein order to easily remove the protease after cleavage (see below) (19, 22, 153) . E. coli maltose-binding protein (MBP), the product of the mal E gene, is exported to the periplasmic space, where it binds specifically with high affinity to maltose SPECIFIC EXAMPLES AND POSSIBLE FUTURE TRENDS or maltodextrins for subsequent transport of these sug-OF AFFINITY TAG APPLICATIONS ars across the cytoplasmic membrane (143) . MBP can Combined Affinity Tags be purified in a single step by affinity chromatography on resins containing cross-linked amylose followed by A common problem in heterologous gene expression is proteolytic degradation. Using an affinity fusion stratcompetitive elution with maltose (144). This fact together with the low cost for amylose resins, mild puri-egy, eventual degradation products of the target protein are copurified with the full-length fusion protein. Gene fication conditions, and the fact that MBP does not contain any cysteine residues that can interfere with fusions can in some cases be used to stabilize labile proteins, but single fusions have shown limited stabilizdisulfide bond formation within the target protein led to the development of an expression system for MBP ing effects (154) . However, it has been observed that dual affinity approaches can have a stabilizing effect on fusion proteins in E. coli allowing affinity purification under mild conditions (Table 1) (145) . Vectors for both several proteolytically sensitive proteins compared to single fusions (154) . Employing a dual affinity approach, intracellular and secreted production have been developed (14, 145) . The vectors designed by Guan and co-as first described for the production of the peptide hormone insulin-like growth factor II (58), two different workers were further developed by the introduction of a cleavage recognition sequence for the factor Xa prote-affinity fusion partners are fused at each end of the target protein. This allows for two successive affinity ase at the C-terminus of MBP to allow release of a target protein fused to MBP (146). Recently, expression purification steps to obtain proteins that by definition only contain both tags and therefore also the central vectors allowing translational fusions to MBP in all reading frames were presented (147) . The possibility target protein (Fig. 4) (58) . Several other combinations of affinity tags have been used in various dual affinity of renaturing an MBP fusion protein from inclusion Note. Abbreviations used: CNBr, cyanogen bromide; b-gal, b-galactosidase; IGF-I, human insulin-like growth factor I; PTH, human parathyroid hormone; MS2, bacteriophage MS2 polymerase; PKCI, protein kinase C inhibitor; RT, room temperature.
a X Å unspecific amino acid. b Also His 6 -protease 3C.
fusion concepts (97, 98, 122, 155) . Thus, the dual affinity Recently, a new affinity fusion partner based on the concept of combined affinity tags was described (27) . A approach points out the advantage, for certain applications, of using a combination of different affinity tags.
general expression vector for N-terminal fusion to an affinity tag combination consisting of an in vivo biotinAlthough a multitude of systems have been described, no single affinity fusion strategy is ideal for all ylated sequence (Bio), a hexahistidine (His 6 ) sequence, and the albumin-binding protein (ABP) was conexpression or purification situations. For example, a fusion to affinity tags derived from normally intracellu-structed (27) . Fusion to the Bio-His 6 -ABP affinity tag allows the use of several commercial agents for deteclar proteins (e.g., the b-galactosidase system) is not applicable when secretion of the product into the per-tion, the possibility of purification under both native iplasm or culture medium is desired. Further, if the purification has to be performed under denaturating conditions, protein ligands such as monoclonal antibodies (mAbs; e.g., anti-FLAG M1 and M2 mAbs) are likely to be unsuitable. Instead, a combination of affinity fusion domains could be introduced into a single fusion partner to obtain general expression vectors for affinity gene fusion strategies, applicable in several situations. Such composite fusion partners consisting of several independent affinity domains could potentially be used for different detection, purification, and immobilization purposes, employing the affinity function most suitable for the situation. However, the affinity domains included should be carefully chosen so that they do not functionally interfere with each other, and each moiety should be able to withstand the purification conditions dictated by the affinity domain requiring the harshest affinity chromatography conditions. For instance, if denaturating conditions are used, as in IMAC purification of proteins containing, e.g., a hexahistidine sequence solubilized from inclusion bodies by urea or Gua-HCl, the other included affinity domains should not be irreversibly denatured during this step, which otherwise may cause aggregation in subsequent renaturation steps. A further advantage of using combined affinity FIG. 4 . The dual affinity fusion concept. The target protein is protags is that different methods may be used for the de-duced as flanked by two different affinity domains and purified using two consecutive affinity chromatography steps.
tection and immobilization of the fusion protein.
and denaturating conditions, and an option to choose from three strong affinity interactions for immobilization. In addition, the ABP part of the affinity tag is soluble and effectively refolded after denaturation, which can be an advantage during an eventual refolding of the fused target protein. The use of this particular combination of affinity tags also demonstrates the advantage of consecutive affinity purification steps for a certain application. Using the ABP-HSA interaction as the first purification, removal of biotinylated host proteins and biotin was possible. This allowed for immobilization of the Bio-His 6 -ABP affinity tag onto a streptavidin chip in a Biacore instrument for biospecific analysis in the next step. Consecutive affinity domains have also been used as C-terminal fusion partners for the evaluation of the best affinity purification method for a rat neurotensin receptor (122) .
Affinity-Tagged Proteases for Site-Specific Cleavage
In gene fusion strategies for the production of native proteins, efficient means for site-specific cleavage of the fusion protein and subsequent removal of the affinity fusion partner are needed. In addition, when enzymatic strategies for cleavage are employed, strategies for the removal of the protease itself must be developed. Special consideration must be taken if the target protein itself has to be further processed to give the desired final product (48, 49) . Careful upstream design of the fusion protein construct using genetic strategies can greatly facilitate the subsequent purification of the target protein and also allow for integrated systems involving coprocessing of the protein and efficient removal of the affinity fusion partner as well as the prote-
FIG. 5.
The affinity fusion protease concept used in the purification ase used for cleavage (22, 49 For general use in site-specific cleavage of fusion proteins comprising relatively large target proteins, proteases such as trypsin, which recognizes basic arginine and the released affinity fusion partner by simple afand lysine residues, are not ideal, because these amino finity chromatography steps. In addition, the desired acids generally occur in proportion to protein size. Al-amount of protease to ensure efficient cleavage may ternative enzymes for broader use in biotechnological be added, since the protease is easily removed after applications should preferably be highly specific prote-cleavage. ases, easy to produce by recombinant means in large Recently, a different affinity-tagged protease, conscale. Interesting candidate enzymes can be found in sisting of coxsackievirus 3C (3C pro ) fused to the serum human picornaviruses, whose maturation relies on the albumin-binding ABP at the N-terminus and His 6 at site-specific cleavage of a large polyprotein precursor the C-terminus (Table 2) , was produced in E. coli and to yield the viral components. Some of these proteases used for the production of a truncated Taq DNA polyhave been described to be functionally produced at high merase (DTaq), according to the principle described in levels in bacterial expression systems (19, 156) , which Fig. 5 (22) . The heat-stable polymerase was produced also would facilitate the production of variants con-as an ABP-DTaq fusion protein having a 3C pro cleavstructed by protein engineering. For example, a kit con-age site introduced between the two protein moieties. taining the 3C protease of rhinovirus (Table 2) fused After HSA-affinity purification and heat elution of to an affinity tag (GST) to be used for specific cleavage ABP-DTaq, the fusion was cleaved using the affinityof target GST-affinity fusion proteins was recently pre-tagged protease ABP-3C pro -His 6 , which allowed for sented (19, PreScission system, Pharmacia Biotech). the recovery of nonfused, fully active DTaq after passage of the cleavage mixture over an HSA column (22) . This enables removal of the affinity-tagged protease Furthermore, an affinity fusion protease can also fa-However, the ABP-HSA interaction was shown to be disrupted at elevated temperatures (ú70ЊC), resulting cilitate the on-column cleavage of an affinity fusion protein immobilized onto an affinity column in cases in in a restored DNA polymerase activity of released Taq DNA polymerase fusion protein. This concept for conwhich the affinity ligand is insensitive to the protease (19, 22) . Recently, a novel system for simultaneous af-trolling the activity of the Taq DNA polymerase was demonstrated to be of practical use to achieve a hotfinity purification and on-column cleavage of affinity fusion proteins was described (157,158; Impact I Sys-start PCR procedure when it is desired to suppress the DNA polymerase activity until temperatures at which tem, New England Biolabs). In this system the target protein is fused to a fusion partner consisting of a modi-unspecific annealing of PCR primers is eliminated are reached. The affinity-immobilization concept for hotfied protein splicing element (intein domain) from S. cerevisiae fused to a chitin-binding affinity tag. After a start PCR was successfully used in full multiple-cycle PCR amplification and was shown to eliminate artione-step affinity immobilization of the fusion protein on a chitin-containing column, free target protein can factual primer-dimer products in the amplification of the human oncogene K-ras gene, in contrast to stanbe eluted after induction (/4ЊC, reducing conditions) of the specific proteolytic activity of the intein domain, dard amplification protocols. Noteworthy was that the ABP-affinity fusion partner was still functional after which itself remains immobilized via the chitin-binding domain (on-column cleavage).
30 PCR cycles, allowing post-PCR reimmobilization of the Taq DNA polymerase fusion protein onto fresh HSA-Sepharose and facilitating the removal of the Heat-Mediated Activation of an Affinity-Immobilized DNA polymerase from reaction mixtures after PCR.
Taq DNA Polymerase
Further studies are needed to determine if this concept Immobilization of enzymes has proven to be a useful for modulating biological activity can also be applied procedure for many applications, due to altered charac-by using other tags and for other widely used enzymes teristics of the immobilized enzyme compared to its (e.g., reverse transcriptase). soluble counterpart (28) . One practical application where such differential activities are utilized was re-Affinity-Assisted in Vivo Folding cently described in which a heat-mediated release of an affinity-immobilized recombinant Taq DNA poly-A new concept for improving the fraction of correctly folded recombinant insulin-like growth factor I (IGF-I) merase (TagTaq) was used to create a so-called hotstart PCR procedure (23) . Taq DNA polymerase was was recently presented (21) . It was demonstrated that coexpression of a specific binding protein, IGF-binding produced in E. coli as fused to the multifunctional BioHis 6 -ABP tag (see above and Ref. (27) ) for affinity pu-protein type 1 (IGFBP-1), significantly increased the relative yield of IGF-I having native disulfide bridges rification and immobilization. HSA-affinity immobilization of the fusion employing the ABP moiety resulted when expressed in a secreted form in E. coli. In addition, a glutathione redox buffer was added to the in a deactivation of the Taq DNA polymerase (Fig. 6) .
as research tools for detection, purification, and immobilization of recombinant proteins expressed in bacteria, yeast, insect cells, plants, and mammalian cells. However, on an industrial scale the use of affinity fusions to facilitate bioprocessing of recombinant proteins has not yet been widely performed. The main reason for this is most likely due to the fact that there has been a demand to produce heterologous proteins in a native form in the ''first generation'' of recombinant products. Affinity fusion strategies thus introduce an additional problem into the downstream processing, since a site-specific cleavage is needed. This review points out new strategies based on affinity fusions, such as the use of affinity-tagged proteases and affinity assisted in vivo folding, which would facilitate downstream bioprocessing by circumventing some of the problems related to proteolytic cleavage of fusion proteins, and thus decrease overall production costs. Such strategies could potentially be implemented in the biopharmaceutical industry in the near future. For protein-level characterization of the immense number of genes or gene fragments emerging from various genome projects, affinity fusion strategies could facilitate
FIG. 7.
The principle of affinity assisted folding used to improve the yield of correctly folded recombinant IGF-I in E. coli via coexpresautomated handling of small-scale protein purification sion of an affinity-tagged IGF-I specific binding protein. The affinity from cell lysates using established 96-well formats tag was subsequently used for efficient and selective recovery of the (159). We believe that the applications described in this native folding form of the target protein.
review make it evident that affinity fusion strategies will find even broader use in the near future. growth medium to enhance formation and breakage of disulfide bonds in the periplasm of the bacteria. In the ACKNOWLEDGMENT presented example, both IGF-I and IGFBP-1 were proWe are grateful to Dr. Lars Abrahmsén for critical reading of the duced as affinity fusions, which facilitated the purifimanuscript.
cation of in vivo assembled heterodimers by different methods (21) .
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